Mallinckrodt Announces Reimbursement Approval in Japan for the...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DUBLIN, March 9, 2023 /PRNewswire-AsiaNet/ -- – CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD –Mallinckrodt plc ( https://c212.net/c/link/?t=0&l=en&o=3801942-1&h=3085666488&u=http%3A%2F%2Fwww.mallinckr...
Authors: LATEST ASIANET NEWS RELEASES